Central Tin Containers
iso9001

No health risk from Bisphenol A

23/03/2015

No consumer health risk from Bisphenol A exposure.

 

EFSA's comprehensive re-evaluation of Bisphenol A (BPA) exposure and toxicity concludes that BPA poses no health risk to consumers of any age group (including unborn children, infants and adolescents) at current exposure levels. Exposure from the diet or from a combination of sources (diet, dust, cosmetics and thermal paper) is under the safe level (the "tolerable daily intake" or TDI).

 

Although new data and refined methodologies have led EFSA experts to considerably reduce the safe level of BPA from 50 micrograms per KG of bodyweight per day to 4mg per kg of bw/day. The highest estimates for dietary exposure and for exposure from a combination of sources. (Aggregated exposure) are three to five times lower than the new TDI.

 

Uncertainties surrounding potential health effects of BPA on the mammary gland, reproductive, metabolic, neurobehavioral and immune systems have been quantified and factored in to the calculation of the TDI. In addition, the TDI is temporary pending the outcome of a long term study in Rats, which will help reduce these uncertainties.

 

Why has EFSA done this Risk Assessment?

 

BPA is a chemical compound used in the manufacture of food contact materials such as re-usable plastic tableware and can coatings (mainly protective linings). Another widespread use of BPA is in thermal paper commonly used for till/cash register receipts. Residues of BPA can migrate into food and beverages and be ingested by the consumer. It can also be absorbed through the skin and via inhalation.

 

Dr Trine Husoy is a member of the EFSA expert panel dealing with food contact materials and chair of the BPA working group. She said "the panel decided to re-evaluate the safety of BPA because of the publication of a huge number of new research studies in recent years."

 

To be as open and transparent as possible, EFSA thoroughly consulted and engaged with national authorities and stakeholders during this risk assessment to ensure that the widest possible range of scientific views and information were considered. According to Dr Husoy, "the public consultation process also helped us to refine our assessment through the submission of additional data and to further clarify important aspects of the opinion such as uncertainties"